Mark N. Feinglos

10.4k citations

146 papers · 7.6k indexed · 2 hit papers · h-index 45

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
Endocrine and Autonomic Systems top 1%
- Regulation of Appetite and Obesity

Papers in

Endocrinology, Diabetes and Metabolism 69
- Diabetes Management and Research 45
- Diabetes Treatment and Management 32
- Diabetes Management and Education 13
Physiology 30
- Adipose Tissue and Metabolism 16
- Diet and metabolism studies 14

Co-authors: Richard S. Surwit Cynthia M. Kuhn Christina Cochrane James A. McCubbin Harold E. Lebovitz James D. Lane Emmanuel C. Opara Judith Rodin
Journals: Diabetes Care (19 papers)Psychosomatic Medicine (10 papers)Diabetes (9 papers)Metabolism (5 papers)Diabetes Research and Clinical Practice (4 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Mark N. Feinglos

145 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and mice 1995 · 539 citations

Peers

Replace Arshag D. Mooradian with:

Arshag D. Mooradian United States

Julio V. Santiago United States

Akihisa Iguchi Japan

Francesco Giorgino Italy

Matthias Nauck Germany

Peter Kopelman United Kingdom

Naoko Tajima Japan

Philippe Lehert Belgium

Elizabeth R. Seaquist United States

Gaetano Crepaldi Italy

Mark N. Feinglos relative to Arshag D. Mooradian United States Arshag D. Mooradian's profile →

Citations per field

00.5×1.6×

Arshag D. Mooradian · 1×

×0.8 3k/4k

EDM

×1.6 606/371

EAS

×0.7 2k/3k

PHYSI

×1.5 193/130

BN

×0.8 616/803

PHARM

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by Mark N. Feinglos

Since Specialization

Citations

This map shows the geographic impact of Mark N. Feinglos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Feinglos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Feinglos more than expected).

Fields of papers citing papers by Mark N. Feinglos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark N. Feinglos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Feinglos. The network helps show where Mark N. Feinglos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark N. Feinglos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark N. Feinglos Line = papers co-authored together Mark N. Feinglos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 14801: Results of the Diabetes LIVE Trial: An Immersive Virtual Environment for Diabetes Self-Management Training and Support Circulation ·Allison Vorderstrasse, Gail D’Eramo Melkus, Wei Pan, Mark N. Feinglos, Sathya Amarasekara, Katherine Pereira, Rachel Scheck, Kathryn Evans Kreider, A. Pineda, Yash Shrivastava, Katherine N. Gibson, Constance Johnson	2019	1
2	Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin Psychosomatic Medicine ·Rhonda M. Merwin, Ashley A. Moskovich, K Li, James D. Lane, Mark N. Feinglos, Richard S. Surwit, Nancy Zucker, Natalia Dmitrieva, Michael A. Babyak, Henri S. Zanker, Muhammad Hafiz Taruligani Sihite	2017	18
3	Education, glucose control, and mortality risks among U.S. older adults with diabetes Diabetes Research and Clinical Practice ·Matthew E. Dupre, Mina Silberberg, Tiia Toivonen, Mark N. Feinglos	2015	31
4	The Effect of Blood Glucose Self-Monitoring Among Inmates With Diabetes Journal of Correctional Health Care ·Nancy C. Mergenthal, Kathleen Mathieson, 임동명, Mark N. Feinglos	2015	15
5	Pilot Study of Caffeine Abstinence for Control of Chronic Glucose in Type 2 Diabetes Europe PMC (PubMed Central) ·James D. Lane, 惠介岡, Richard S. Surwit, Cynthia M. Kuhn, Mark N. Feinglos	2012	6
6	Hostility and Fasting Glucose in African American Women Psychosomatic Medicine ·Anastasia Georgiades, James D. Lane, Stephen H. Boyle, Beverly H. Brummett, John C. Barefoot, Cynthia M. Kuhn, Mark N. Feinglos, Redford B. Williams, Rhonda M. Merwin, Sharon Minda, Ilene C. Siegler, Richard S. Surwit	2009	16
7	Type 2 Diabetes Mellitus Humana Press eBooks ·Mark N. Feinglos	2008	13
8	Exenatide and rimonabant: New treatments that may be useful in the management of diabetes and obesity Current Diabetes Reports ·Jennifer B. Green, Mark N. Feinglos	2007	5
9	Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm International Journal of Clinical Practice ·Seblewengel Lemma, Mark N. Feinglos	2007	15
10	Changes in Depressive Symptoms and Glycemic Control in Diabetes Mellitus Psychosomatic Medicine ·Anastasia Georgiades, Nancy Zucker, Kelli E. Friedman, 刘利锋, Katherine L. Applegate, James D. Lane, Mark N. Feinglos, Richard S. Surwit	2007	78
11	Diabetes-Related Knowledge, Atherosclerotic Risk Factor Control, and Outcomes in Acute Coronary Syndromes The American Journal of Cardiology ·A.M. Shuker, L. Kristin Newby, Darren K. McGuire, Vic Hasselblad, Mark N. Feinglos, E. Magnus Ohman	2005	19
12	Effects of liraglutide (NN2211), a long‐acting GLP‐1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes Diabetic Medicine ·Mark N. Feinglos, Mohammed Saad, F X Pi-Sunyer, Bob An, Nuñez Ortega, (unknown)	2005	115
13	The combination oral and nutritional treatment of late‐onset diabetes mellitus (CONTROL DM) trial results Diabetic Medicine ·P. Slingerland, David C. Goff, Edward W. Lipkin, David M. Herrington, John H. Summerson, Michael W. Steffes, Chenqian Zhu, Lois Jovanovič, Mark N. Feinglos, Jeffrey L. Probstfield, Mary Ann Banerji, David J. Pettitt, Jeff D. Williamson	2004	16
14	Diabetes is associated with a higher risk of death than is prior myocardial infarction in the setting of coronary disease: results from the Duke cardiovascular database Journal of the American College of Cardiology ·Darren K. McGuire, Sunil V. Rao, Peter J. Joski, Gregory W. Barsness, Eric D. Peterson, James G. Jollis, Mark N. Feinglos, Christopher B. Granger	2002	3
15	Insulin analogues: New therapies for type 2 diabetes mellitus Current Diabetes Reports ·M. Angelyn Bethel, Mark N. Feinglos	2002	5
16	Therapy of type 2 diabetes, cardiovascular death, and the UGDP American Heart Journal ·Mark N. Feinglos, M. Angelyn Bethel	1999	36
17	THE USE OF INSULIN SECRETAGOGUES IN THE TREATMENT OF TYPE 2 DIABETES Primary Care Clinics in Office Practice ·SEMIRA MEKONNEN, Geoffrey C. Hughes, Mark N. Feinglos	1999	14
18	Glycogen synthase: a putative locus for diet-induced hyperglycemia. Journal of Clinical Investigation ·Michael F. Seldin, D. M. Mott, Dattatray Bhat, Asian American Women's Youth Consumer Culture, Cynthia M. Kuhn, Stephen F. Kingsmore, Clifton Bogardus, Emmanuel C. Opara, Mark N. Feinglos, Richard S. Surwit	1994	29
19	Regional fat distribution and metabolism in a new mouse model ( ) of non-insulin-dependent diabetes mellitus Metabolism ·M Rebuffé-Scrive, Richard S. Surwit, Mark N. Feinglos, Bryan Thibeault, Judith Rodin	1993	111
20	Insulin Resistance in Patients with Insulin Independent Diabetes Mellitus: Partial Amelioration by the Sulfonylurea Glipizide Advances in experimental medicine and biology ·Harold E. Lebovitz, Mark N. Feinglos	1979	3

About Mark N. Feinglos

Mark N. Feinglos is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Archeology, Family Practice and Cardiology and Cardiovascular Medicine, having authored 146 papers that have together received 7.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (45 papers), Diabetes Treatment and Management (32 papers), Metabolism, Diabetes, and Cancer (22 papers), Pancreatic function and diabetes (22 papers), Adipose Tissue and Metabolism (16 papers), Diet and metabolism studies (14 papers), Diabetes Management and Education (13 papers) and Diabetes and associated disorders (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Endocrine and Autonomic Systems (606 citations), Physiology (2.0k citations), Behavioral Neuroscience (193 citations) and Pharmacology (616 citations). Mark N. Feinglos has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Richard S. Surwit, Cynthia M. Kuhn, Christina Cochrane, James A. McCubbin, Harold E. Lebovitz, James D. Lane, Emmanuel C. Opara, Judith Rodin, M Rebuffé-Scrive and Mark S. Schneider. Their work appears in journals such as Diabetes Care, Psychosomatic Medicine, Diabetes, Metabolism and Diabetes Research and Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact